Sleep Disorders Trial, Recruiting (NCT04588233)

Sleep Disorders Trial, Recruiting NCT04588233 Sponsor: Loma Linda University Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT04588233 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You report having trouble sleeping, such as difficulty falling asleep, waking up during the night, or waking up too early.
You are between 13 and 17 years old.
You are able to understand, read, and write in English.
You have never used melatonin before.

Who may not be able to join:

You have obesity.
You are currently taking any medication for mental health conditions.
You currently take any drugs or supplements that are known to affect sleep.
You have a history of a head injury or concussion where you were unconscious for more than 1 minute.
You drink more than one caffeinated drink (such as coffee, energy drinks, or soda) every day.
You show signs of, or are at risk for, a physical sleep disorder such as sleep apnea (breathing problems during sleep) or restless leg syndrome (uncomfortable feelings in the legs at night) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tori Van Dyk, PhD, Loma Linda University

Phone: 909-558-7412

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04588233

Sponsor: Loma Linda University

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 909-558-7412

More information: https://clinicaltrials.gov/study/NCT04588233

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You report having trouble sleeping, such as difficulty falling asleep, waking up during the night, or waking up too early.
You are between 13 and 17 years old.
You are able to understand, read, and write in English.
You have never used melatonin before.

Who may not be able to join:

You have obesity.
You are currently taking any medication for mental health conditions.
You currently take any drugs or supplements that are known to affect sleep.
You have a history of a head injury or concussion where you were unconscious for more than 1 minute.
You drink more than one caffeinated drink (such as coffee, energy drinks, or soda) every day.
You show signs of, or are at risk for, a physical sleep disorder such as sleep apnea (breathing problems during sleep) or restless leg syndrome (uncomfortable feelings in the legs at night) (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Loma Linda University

Registry

ClinicalTrials.gov

Start date

15 September 2021

Est. completion

1 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Objective Sleep Duration During Melatonin Administration; Change in Objective Sleep Duration During Placebo Administration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov